INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Top HEOR Trends

  Real-world evidence (RWE) offers insights into the effectiveness of medical treatments in everyday settings, with various stakeholders utilize RWE to enhance healthcare.

• AI‑Readiness Checklist: Is Your Clinical Data Environment Ready?

  AI impact depends on solid data practices, good governance, and team alignment. This piece highlights what to assess and how organizations can build readiness for future initiatives.

• Advantages Of Integrated Clinical Trial Management

  Disconnected trial systems slow sites and patients. Centralizing logistics, payments, and data improves visibility, reduces admin work, and keeps enrollment on track for more patient‑focused studies.

• Protocol Design Choices That Trigger IRB And Regulatory Requirements

  Learn how protocol choices like AI, adaptive designs, and decentralized methods impact IRB review, participant protections, consent, and key regulatory requirements in clinical research.

• Navigating The Enrollment Bottleneck In Early Oncology Trials

  1/12/2026

  Slow oncology trial enrollment raises costs and delays progress. AI prescreening, patient-focused engagement, and early pharmacology studies help accelerate recruitment and optimize trial design.

• The Immunotherapy Revolution's Path To Precision

  10/27/2025

  Learn how comprehensive immune profiling and translational models can illuminate these mechanisms, inform dose selection, and guide the next generation of immunotherapies toward safer, more targeted innovation.

• Cytokine Release Syndrome Monitoring

  2/7/2025

  Here we introduce an innovative risk-monitoring solution aimed at mitigating Cytokine Release Syndrome (CRS), a critical complication in immunotherapy that often leads to prolonged hospitalization.

• How Sponsors Can Ensure Their Sites Are Aligned With ICH E6 R3

  4/14/2026

  Updated GCP expectations reshape sponsor–site collaboration. Clear guidance on systems, data governance, and monitoring reduces risk, strengthens oversight, and supports compliance with ICH E6(R3).

• Central Laboratory Solutions

  9/29/2026

  Global clinical trials need central laboratory networks able to scale across countries while keeping biomarker and biospecimen data consistent from one study site to the next.